drugset / Trial / NCT01318889

Dexpanthenol Mouthwash to Treat Oral Mucositis

NCT01318889

RandomizedParallel-groupDouble-blindTreatment

Summary

Oral mucositis can be a significant problem for cancer patients. It is typically associated with pain and increased risk of infection and can lead to impaired nutritional status and inadequate hydration.it can be seen in the patient population receiving high-dose head and neck radiation therapy (85%-100%). Topical dexpanthenol acts like a moisturizer, improving stratum corneum hydration, reducing transepidermal water loss and maintaining skin softness and elasticity. The stimulation of epithelization, granulation and mitigation of itching were the most prominent effects of formulations containing dexpanthenol. The investigators suppose that dexpanthenol mouth wash may improve oral mucositis.

Timeline

Start
2010-09
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexpanthenol Small molecule 5 % Topical
Subject Dexpanthenol Small molecule 10 ml Topical

Indications